Feasibility of adjuvant chemotherapy with doxorubicin plus docetaxel followed by sequential capecitabine in patients with node positive breast cancer.

被引：0
|
作者：
Lara, R
Mayordomo, JI
Modolell, A
Burillo, M
Sanz, J
Murillo, L
Janariz, J
Perez, V
Andres, R
Tres, A
机构：
[1] Hosp Clin Univ, Zaragoza, Spain
[2] Inst Oncol Corachan, Barcelona, Spain
[3] Hosp San Jorge, Huesca, Spain
[4] Hosp Tudela, Tudela, Spain
[5] Hosp Creu Roja De Barcelona, Barcelona, Spain
[6] Hosp Arritxaca, Murcia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
782
引用
收藏
页码：72S / 72S
页数：1
相关论文
共 50 条
  • [21] First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
    Liang, Xu
    Yan, Ying
    Wang, Lina
    Song, Guohong
    Di, Lijun
    Jiang, Hanfang
    Wang, Chaoying
    Li, Huiping
    ONCOLOGY LETTERS, 2015, 9 (02) : 987 - 993
  • [22] A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer
    Yoo, Changhoon
    Kim, Sung-Bae
    Ahn, Jin-Hee
    Kim, Jeong Eun
    Jung, Kyung Hae
    Gong, Gyung-Yub
    Son, Byung-Ho
    Ahn, Sei-Hyun
    Ahn, Seung Do
    Kim, Hak-Hee
    Shin, Hee Jung
    Kim, Woo Kun
    CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 406 - 415
  • [23] Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients:: The FNCLCC PACS 01 trial
    Roche, Henri
    Fumoleau, Pierre
    Spielmann, Marc
    Canon, Jean-Luc
    Delozier, Thierry
    Serin, Daniel
    Symann, Michel
    Kerbrat, Pierre
    Soulie, Patrick
    Eichler, Francoise
    Viens, Patrice
    Monnier, Alain
    Vindevoghel, Anita
    Campone, Mario
    Goudier, Marie-Josephe
    Bonneterre, Jacques
    Ferrero, Jean-Marc
    Martin, Anne-Laure
    Geneve, Jean
    Asselain, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5664 - 5671
  • [24] Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer
    Saeki T.
    Takashima S.
    Breast Cancer, 2004, 11 (2) : 116 - 120
  • [25] Adjuvant docetaxel for node-positive breast cancer
    Noronha, V
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (09): : 954 - 954
  • [26] Adjuvant docetaxel for node-positive breast cancer
    Martin, M
    Pienkowski, T
    Mackey, J
    Pawlicki, M
    Guastalla, JP
    Weaver, C
    Tomiak, E
    Al-Tweigeri, T
    Chap, L
    Juhos, E
    Guevin, R
    Howell, A
    Fornander, T
    Hainsworth, J
    Coleman, R
    Vinholes, J
    Modiano, M
    Pinter, T
    Tang, SC
    Colwell, B
    Prady, C
    Provencher, L
    Walde, D
    Rodriguez-Lescure, A
    Hugh, J
    Loret, C
    Rupin, M
    Blitz, S
    Jacobs, P
    Murawsky, M
    Riva, A
    Vogel, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22): : 2302 - 2313
  • [27] Prophylactic pegfilgrastim support with adjuvant docetaxel, doxorubicin and cyclophosphamide (TAC) in node-positive breast cancer patients
    Rifa, Juli
    Del Alba, A. Gonzalez
    Perello, A.
    Alarcon, J.
    Avella, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 112 - 112
  • [28] Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
    Gradishar, WJ
    Wedam, SB
    Jahanzeb, M
    Erban, J
    Limentani, SA
    Tsai, KT
    Olsen, SR
    Swain, SM
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1297 - 1304
  • [29] Neoadjuvant sequential treatment with epirubicin plus docetaxel followed by capecitabine plus docetaxel in locally advanced breast cancer:: XELOGET:: a pilot study.
    Bourgeois, H.
    Soulie, P.
    Delva, R.
    Abadie-Lacourtoisei, S.
    Van Praagh, I
    Mouret-Reynier, M-A
    Lortholary, A.
    Chieze, S.
    Raban, N.
    Mac Grogan, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S155 - S155
  • [30] Cost effectiveness of adjuvant chemotherapy with cyclophosphamide plus methotrexate plus fluorouracil in patients with node positive breast cancer
    Messori, A
    Becagli, P
    Trippoli, S
    Tendi, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (02) : 111 - 116
12345